- Home
- IMA vs OM Comparison
IMA vs OM Comparison
Compare IMA & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMA | OM |
|---|---|---|
| Founded | 2019 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 74.5M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IMA | OM |
|---|---|---|
| Price | $5.33 | $4.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $16.00 | $13.33 |
| AVG Volume (30 Days) | 8.9K | ★ 127.5K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $800,000.00 | ★ $119,476,000.00 |
| Revenue This Year | N/A | $9.29 |
| Revenue Next Year | N/A | $10.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $3.94 | $3.00 |
| 52 Week High | $13.98 | $16.16 |
Technical Indicators
Market Signals| Indicator | IMA | OM |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 40.87 |
| Support Level | $3.94 | $4.07 |
| Resistance Level | $6.11 | $4.88 |
| Average True Range (ATR) | 0.31 | 0.33 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 2.29 | 1.65 |
Price Performance
Historical ComparisonAbout IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.